Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 2 Results

Intervention Indication Therapeutic Area Year Actions
Rivaroxaban for reducing the risk of major thrombotic vascular events in symptomatic peripheral arterial disease patients with a recent lower extremity revascularisation procedure Rivaroxaban (Xarelto; BAY 59-7939) Peripheral arterial disease (PAD) Cardiovascular System 2019 View  |  Download
Semaglutide for treating peripheral arterial disease (PAD) and type 2 diabetes Semaglutide (Ozempic) Peripheral arterial disease (PAD) , Type 2 diabetes Cardiovascular System , Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications